Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07469228 · ClinicalTrials.gov registry record · Phase 1
A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris
A Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 1,043
- Enrollment target
NCT07469228 is a Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 1,043 participants.
The verdict
NCT07469228, a Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1,043 participants
- Enrollment target
Study Summary
To demonstrate the efficacy, therapeutic equivalence and safety of tretinoin gel microsphere, 0.04% (Sun Pharmaceutical Industries, Inc.) and RETIN-A MICRO ® (tretinoin) gel microsphere, 0.04% (Reference Listed Drug) in the treatment of acne vulgaris.
Interventions
- DRUG Placebo Control
- DRUG Tretinoin Gel Microsphere, 0.04%
- DRUG RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,043 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2025-12-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07469228
The ClinicalTrials.gov registry entry for NCT07469228 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1,043 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Control is the first listed.
NCT07469228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07469228 about?
NCT07469228 is a clinical study titled "A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris". To demonstrate the efficacy, therapeutic equivalence and safety of tretinoin gel microsphere, 0.04% (Sun Pharmaceutical Industries, Inc.) and RETIN-A MICRO ® (tretinoin) gel microsphere, 0.04% (Reference Listed Drug) in the treatment of acne vulgaris.
What is the current status of trial NCT07469228?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1,043 participants. The study started on 2025-08-04. Estimated completion is 2025-12-15.
What interventions are being tested in trial NCT07469228?
The interventions under investigation include: Placebo Control (DRUG), Tretinoin Gel Microsphere, 0.04% (DRUG), RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.04% (DRUG).
Who is sponsoring clinical trial NCT07469228?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.